Literature DB >> 8394919

Lamotrigine, phenytoin and carbamazepine interactions on the sodium current present in N4TG1 mouse neuroblastoma cells.

D G Lang1, C M Wang, B R Cooper.   

Abstract

Lamotrigine is a chemically novel anticonvulsant drug that has been reported to inhibit veratrine-induced neurotransmitter release from cortical slices in vitro. To characterize further the mechanism of action of lamotrigine, we have investigated the effects of this drug together with the anticonvulsant drugs phenytoin and carbamazepine on voltage-sensitive sodium channels present in N4TG1 mouse neuroblastoma clonal cells. Lamotrigine, phenytoin and carbamazepine produced a tonic inhibition of sodium channels with IC50 values of 91, 58 and 140 microM, respectively. At a concentration of 100 microM, all compounds shifted the voltage-dependency of steady-state inactivation toward more negative potentials by 7 to 15 mV, slowed the rate of recovery from inactivation and produced a use-dependent inhibition of sodium channels. Our data show that lamotrigine inhibits sodium channels in a manner that is similar to that produced by phenytoin and carbamazepine. This inhibition of neuronal activity is consistent with the reduction of glutamate release that was previously reported in neurochemical studies, and it expands our understanding of the mechanism of action of this anticonvulsant drug.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8394919

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  27 in total

Review 1.  Pharmacological management of neuropathic pain.

Authors:  Gary McCleane
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

2.  Overview of drugs used for epilepsy and seizures: etiology, diagnosis, and treatment.

Authors:  Marvin M Goldenberg
Journal:  P T       Date:  2010-07

3.  Flufenamic acid decreases neuronal excitability through modulation of voltage-gated sodium channel gating.

Authors:  Hau-Jie Yau; Gytis Baranauskas; Marco Martina
Journal:  J Physiol       Date:  2010-08-19       Impact factor: 5.182

Review 4.  Central mechanism of action of antimigraine prophylactic drugs.

Authors:  Gerardo Casucci; Veronica Villani; Fabio Frediani
Journal:  Neurol Sci       Date:  2008-05       Impact factor: 3.307

5.  Interaction of the antiepileptic drug lamotrigine with recombinant rat brain type IIA Na+ channels and with native Na+ channels in rat hippocampal neurones.

Authors:  X Xie; B Lancaster; T Peakman; J Garthwaite
Journal:  Pflugers Arch       Date:  1995-07       Impact factor: 3.657

6.  Reverse translational analysis of clinically reported, lamotrigine-induced cardiovascular adverse events using the halothane-anesthetized dogs.

Authors:  Ai Goto; Mihoko Hagiwara-Nagasawa; Ryuichi Kambayashi; Yoshio Nunoi; Hiroko Izumi-Nakaseko; Shinichi Kawai; Yoshinori Takei; Akio Matsumoto; Atsushi Sugiyama
Journal:  Heart Vessels       Date:  2020-11-02       Impact factor: 2.037

7.  The effects of anticonvulsants on 4-aminopyridine-induced bursting: in vitro studies on rat peripheral nerve and dorsal roots.

Authors:  G Lees
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

8.  Effects of the antianginal drug, ranolazine, on the brain sodium channel Na(V)1.2 and its modulation by extracellular protons.

Authors:  C H Peters; S Sokolov; S Rajamani; P C Ruben
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

9.  Effects of besipirdine at the voltage-dependent sodium channel.

Authors:  L Tang; C P Smith; F P Huger; S Kongsamut
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

10.  The external pore loop interacts with S6 and S3-S4 linker in domain 4 to assume an essential role in gating control and anticonvulsant action in the Na(+) channel.

Authors:  Ya-Chin Yang; Jui-Yi Hsieh; Chung-Chin Kuo
Journal:  J Gen Physiol       Date:  2009-08       Impact factor: 4.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.